MedCity News February 3, 2022
Arundhati Parmar

Formus Labs is expecting to get the regulatory nod from the FDA to be able to sell its fully-automated 3D planning technology for joint replacement surgeries in the second quarter and has partnered with orthopedic surgery heavyweight for a global distribution program.

A New Zealand startup that makes fully automated 3D orthopedic surgery planning software announced Wednesday that it has raised $5 million and struck a partnership with Zimmer Biomet for co-development and global distribution of its technology.

Formus Labs, which bills itself as the world’s first world’s “first automated 3D planner for joint replacement surgeries” received the investment from lead investor GD1 (Global from Day 1), and others including Punakaiki Fund, Icehouse Ventures, Pacific Channel, and Flying Kiwis.The company...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: 3D Printing, Investments, Technology, Trends
Related Articles:
How 3D Printing Impacts Radiology
Ricoh’s 3D Printing Improves Surgical Accuracy and Safety One Layer at a Time
3D-printed hydrogel enables continuous drug delivery via contact lens
Improved 3D printed blood vessels thanks to bioink with DNA
DNA-based bioink technology enables precise 3D-printing of blood vessels

Share This Article